Recent studies show the surging popularity of Ozempic, Wegovy and similar drugs for weight loss is driving employer health ...

Patients with colon cancer using GLP-1 receptor agonists (the class of drugs behind treatments like Ozempic, Wegovy, and ...

Novo Nordisk A/S faces intensifying GLP-1 competition, notably from Eli Lilly, prompting price cuts for Wegovy. Learn more ...

Trump’s GLP-1 price deal slashes costs and expands selective Medicare coverage—threatening telehealth startups and sparking a ...

GLP-1 medications may help colon cancer patients live longer by reducing inflammation and improving metabolic health, UC San ...

About one in eight American adults are now taking GLP-1 drugs like Ozempic, Wegovy, Zepbound, and Mounjaro, a new survey ...

As you might expect, the competition to win a share of the expanding GLP-1 market is fierce right now, with giants Novo ...

This week, the White House announced a deal with Eli Lilly and Novo Nordisk to lower the cost of their GLP-1 weight loss ...

As the buzz around GLP-1 medications grew to a fever pitch over the past two years, many digital health and telehealth ...

Robbie Williams warns GLP-1 drugs may cause vision loss. What does this mean for food & beverage innovation and natural ...

President Donald Trump says Americans could soon pay far less for GLP-1 medications used for diabetes, obesity, and heart ...

Lactalis has joined the likes of Danone and Two Spoons as one of the first dairy companies to market a ‘GLP-1-friendly’ ...